Affluent Medical SA (EPA:AFME)
France · Delayed Price · Currency is EUR 1.500
+0.060 (4.17%)
Aug 15, 2025, 5:37 PM CET
Affluent Medical Revenue
In the year 2024, Affluent Medical had annual revenue of 5.35M EUR with 337.09% growth. Affluent Medical had revenue of 4.69M in the half year ending December 31, 2024, with 639.59% growth.
Revenue
5.35M
Revenue Growth
+337.09%
P/S Ratio
11.03
Revenue / Employee
81.06K
Employees
63
Market Cap
59.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.35M | 4.13M | 337.09% |
| Dec 31, 2023 | 1.22M | -115.00K | -8.59% |
| Dec 31, 2022 | 1.34M | -112.00K | -7.72% |
| Dec 31, 2021 | 1.45M | 627.00K | 76.09% |
| Dec 31, 2020 | 824.00K | -605.00K | -42.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |